536 related articles for article (PubMed ID: 27483439)
1. Benefits of Intraaortic Balloon Support for Myocardial Infarction Patients in Severe Cardiogenic Shock Undergoing Coronary Revascularization.
Mao CT; Wang JL; Chen DY; Tsai ML; Lin YS; Cherng WJ; Wang CH; Wen MS; Hsieh IC; Hung MJ; Chen CC; Chen TH
PLoS One; 2016; 11(8):e0160070. PubMed ID: 27483439
[TBL] [Abstract][Full Text] [Related]
2. Intraaortic balloon support for myocardial infarction with cardiogenic shock.
Thiele H; Zeymer U; Neumann FJ; Ferenc M; Olbrich HG; Hausleiter J; Richardt G; Hennersdorf M; Empen K; Fuernau G; Desch S; Eitel I; Hambrecht R; Fuhrmann J; Böhm M; Ebelt H; Schneider S; Schuler G; Werdan K;
N Engl J Med; 2012 Oct; 367(14):1287-96. PubMed ID: 22920912
[TBL] [Abstract][Full Text] [Related]
3. The effectiveness of intra-aortic balloon pump for myocardial infarction in patients with or without cardiogenic shock: a meta-analysis and systematic review.
Zheng XY; Wang Y; Chen Y; Wang X; Chen L; Li J; Zheng ZG
BMC Cardiovasc Disord; 2016 Jul; 16(1):148. PubMed ID: 27391391
[TBL] [Abstract][Full Text] [Related]
4. Comparison of hospital mortality with intra-aortic balloon counterpulsation insertion before versus after primary percutaneous coronary intervention for cardiogenic shock complicating acute myocardial infarction.
Abdel-Wahab M; Saad M; Kynast J; Geist V; Sherif MA; Richardt G; Toelg R
Am J Cardiol; 2010 Apr; 105(7):967-71. PubMed ID: 20346314
[TBL] [Abstract][Full Text] [Related]
5. Predictors of mortality in patients with cardiogenic shock treated with primary percutaneous coronary intervention and intra-aortic balloon counterpulsation.
Schwarz B; Abdel-Wahab M; Robinson DR; Richardt G
Med Klin Intensivmed Notfmed; 2016 Nov; 111(8):715-722. PubMed ID: 26596273
[TBL] [Abstract][Full Text] [Related]
6. Association of Use of an Intravascular Microaxial Left Ventricular Assist Device vs Intra-aortic Balloon Pump With In-Hospital Mortality and Major Bleeding Among Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock.
Dhruva SS; Ross JS; Mortazavi BJ; Hurley NC; Krumholz HM; Curtis JP; Berkowitz A; Masoudi FA; Messenger JC; Parzynski CS; Ngufor C; Girotra S; Amin AP; Shah ND; Desai NR
JAMA; 2020 Feb; 323(8):734-745. PubMed ID: 32040163
[TBL] [Abstract][Full Text] [Related]
7. Impella Support for Acute Myocardial Infarction Complicated by Cardiogenic Shock.
Schrage B; Ibrahim K; Loehn T; Werner N; Sinning JM; Pappalardo F; Pieri M; Skurk C; Lauten A; Landmesser U; Westenfeld R; Horn P; Pauschinger M; Eckner D; Twerenbold R; Nordbeck P; Salinger T; Abel P; Empen K; Busch MC; Felix SB; Sieweke JT; Møller JE; Pareek N; Hill J; MacCarthy P; Bergmann MW; Henriques JPS; Möbius-Winkler S; Schulze PC; Ouarrak T; Zeymer U; Schneider S; Blankenberg S; Thiele H; Schäfer A; Westermann D
Circulation; 2019 Mar; 139(10):1249-1258. PubMed ID: 30586755
[TBL] [Abstract][Full Text] [Related]
8. Intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP SHOCK Trial for attenuation of multiorgan dysfunction syndrome.
Prondzinsky R; Lemm H; Swyter M; Wegener N; Unverzagt S; Carter JM; Russ M; Schlitt A; Buerke U; Christoph A; Schmidt H; Winkler M; Thiery J; Werdan K; Buerke M
Crit Care Med; 2010 Jan; 38(1):152-60. PubMed ID: 19770739
[TBL] [Abstract][Full Text] [Related]
9. Intraaortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock: design and rationale of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial.
Thiele H; Schuler G; Neumann FJ; Hausleiter J; Olbrich HG; Schwarz B; Hennersdorf M; Empen K; Fuernau G; Desch S; de Waha S; Eitel I; Hambrecht R; Böhm M; Kurowski V; Lauer B; Minden HH; Figulla HR; Braun-Dullaeus RC; Strasser RH; Rochor K; Maier SK; Möllmann H; Schneider S; Ebelt H; Werdan K; Zeymer U
Am Heart J; 2012 Jun; 163(6):938-45. PubMed ID: 22709745
[TBL] [Abstract][Full Text] [Related]
10. Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial.
Thiele H; Zeymer U; Neumann FJ; Ferenc M; Olbrich HG; Hausleiter J; de Waha A; Richardt G; Hennersdorf M; Empen K; Fuernau G; Desch S; Eitel I; Hambrecht R; Lauer B; Böhm M; Ebelt H; Schneider S; Werdan K; Schuler G;
Lancet; 2013 Nov; 382(9905):1638-45. PubMed ID: 24011548
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcomes of the intra-aortic balloon pump for resuscitated patients with acute myocardial infarction complicated by cardiac arrest.
Kim HK; Jeong MH; Ahn Y; Sim DS; Chae SC; Kim YJ; Hur SH; Seong IW; Hong TJ; Choi DH; Cho MC; Kim CJ; Seung KB; Jang YS; Rha SW; Bae JH; Cho JG; Park SJ;
J Cardiol; 2016 Jan; 67(1):57-63. PubMed ID: 25982668
[TBL] [Abstract][Full Text] [Related]
12. Role of intra-aortic balloon pump counterpulsation in the treatment of acute myocardial infarction complicated by cardiogenic shock: Evidence from the Portuguese nationwide registry.
Timóteo AT; Nogueira MA; Rosa SA; Belo A; Ferreira RC;
Eur Heart J Acute Cardiovasc Care; 2016 Nov; 5(7):23-31. PubMed ID: 26373810
[TBL] [Abstract][Full Text] [Related]
13. Intra-Aortic Balloon Pump Counterpulsation during Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction and Cardiogenic Shock: Insights from the British Columbia Cardiac Registry.
Iqbal MB; Robinson SD; Ding L; Fung A; Aymong E; Chan AW; Hodge S; Della Siega A; Nadra IJ;
PLoS One; 2016; 11(2):e0148931. PubMed ID: 26870950
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular outcomes using intra-aortic balloon pump in high-risk acute myocardial infarction with or without cardiogenic shock: a meta-analysis.
Bahekar A; Singh M; Singh S; Bhuriya R; Ahmad K; Khosla S; Arora R
J Cardiovasc Pharmacol Ther; 2012 Mar; 17(1):44-56. PubMed ID: 21335478
[TBL] [Abstract][Full Text] [Related]
15. Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK?
Sanborn TA; Sleeper LA; Bates ER; Jacobs AK; Boland J; French JK; Dens J; Dzavik V; Palmeri ST; Webb JG; Goldberger M; Hochman JS
J Am Coll Cardiol; 2000 Sep; 36(3 Suppl A):1123-9. PubMed ID: 10985715
[TBL] [Abstract][Full Text] [Related]
16. Correlates for mortality in patients presented with acute myocardial infarct complicated by cardiogenic shock.
Minha S; Barbash IM; Dvir D; Ben-Dor I; Loh JP; Pendyala LK; Satler LF; Pichard AD; Torguson R; Waksman R
Cardiovasc Revasc Med; 2014 Jan; 15(1):13-7. PubMed ID: 24444472
[TBL] [Abstract][Full Text] [Related]
17. A Comparison of In-Hospital Outcomes Between the Use of Impella and IABP in Acute Myocardial Infarction Cardiogenic Shock Undergoing Percutaneous Coronary Intervention.
Jin C; Yandrapalli S; Yang Y; Liu B; Aronow WS; Naidu SS
J Invasive Cardiol; 2022 Feb; 34(2):E98-E103. PubMed ID: 35100554
[TBL] [Abstract][Full Text] [Related]
18. "Smoker's paradox" in patients with cardiogenic shock complicating myocardial infarction - A substudy of the IABP-SHOCK II-trial and registry.
Saad M; Fuernau G; Desch S; Eitel I; Jung C; Pöss J; Schneider S; Schuler G; Werdan K; Zeymer U; Thiele H
Int J Cardiol; 2016 Nov; 222():775-779. PubMed ID: 27521557
[TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of atrial fibrillation in cardiogenic shock complicating acute myocardial infarction: a substudy of the IABP-SHOCK II trial.
de Waha S; Schoene K; Fuernau G; Desch S; Eitel I; Pöss J; Meyer-Saraei R; Eitel C; Tilz R; Schuler G; Werdan K; Schneider S; Ouarrak T; Zeymer U; Thiele H
Clin Res Cardiol; 2018 Mar; 107(3):233-240. PubMed ID: 29127472
[TBL] [Abstract][Full Text] [Related]
20. Impact of intra-aortic balloon pump support initiated before versus after primary percutaneous coronary intervention in patients with cardiogenic shock from acute myocardial infarction.
Cheng JM; van Leeuwen MA; de Boer SP; Wai MC; den Uil CA; Jewbali LS; van Geuns RJ; Kardys I; van Domburg RT; Boersma E; Zijlstra F; Akkerhuis KM
Int J Cardiol; 2013 Oct; 168(4):3758-63. PubMed ID: 23830073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
